Integrated Core Strategies (US) LLC 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-10 4:36 pm Sale |
2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Integrated Core Strategies (US) LLC | 125,259 5.100% |
-6,372 (-4.84%) |
Filing |
| 2022-12-01 4:07 pm Purchase |
2022-11-23 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Integrated Core Strategies (US) LLC | 131,631 5.300% |
131,631 (New Position) |
Filing |